nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CA2—osteoporosis	0.385	1	CbGaD
Methazolamide—CA14—Zoledronate—osteoporosis	0.142	0.312	CbGbCtD
Methazolamide—CA12—Zoledronate—osteoporosis	0.101	0.221	CbGbCtD
Methazolamide—CA2—Zoledronate—osteoporosis	0.0815	0.179	CbGbCtD
Methazolamide—SLC22A6—Conjugated Estrogens—osteoporosis	0.0174	0.0383	CbGbCtD
Methazolamide—CYP2C9—Estropipate—osteoporosis	0.0169	0.0372	CbGbCtD
Methazolamide—CYP2C19—Cholecalciferol—osteoporosis	0.0105	0.023	CbGbCtD
Methazolamide—CYP3A4—Estropipate—osteoporosis	0.00984	0.0216	CbGbCtD
Methazolamide—CYP3A4—Calcitriol—osteoporosis	0.00984	0.0216	CbGbCtD
Methazolamide—CYP2C9—Cholecalciferol—osteoporosis	0.00872	0.0191	CbGbCtD
Methazolamide—CYP2C19—Estradiol—osteoporosis	0.00846	0.0186	CbGbCtD
Methazolamide—CYP2D6—Cholecalciferol—osteoporosis	0.00798	0.0175	CbGbCtD
Methazolamide—CYP3A4—Ergocalciferol—osteoporosis	0.00787	0.0173	CbGbCtD
Methazolamide—CYP2C9—Estradiol—osteoporosis	0.00703	0.0154	CbGbCtD
Methazolamide—CYP3A4—Raloxifene—osteoporosis	0.00657	0.0144	CbGbCtD
Methazolamide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00634	0.0139	CbGbCtD
Methazolamide—CYP3A4—Cholecalciferol—osteoporosis	0.00507	0.0111	CbGbCtD
Methazolamide—CYP3A4—Conjugated Estrogens—osteoporosis	0.00466	0.0102	CbGbCtD
Methazolamide—CYP3A4—Estradiol—osteoporosis	0.00409	0.00897	CbGbCtD
Methazolamide—Acetazolamide—CA2—osteoporosis	0.00346	1	CrCbGaD
Methazolamide—Stevens-Johnson syndrome—Etidronic acid—osteoporosis	0.000622	0.00701	CcSEcCtD
Methazolamide—Confusional state—Calcium Acetate—osteoporosis	0.000614	0.00693	CcSEcCtD
Methazolamide—Agranulocytosis—Etidronic acid—osteoporosis	0.000585	0.0066	CcSEcCtD
Methazolamide—Anorexia—Calcium Acetate—osteoporosis	0.000581	0.00655	CcSEcCtD
Methazolamide—Paraesthesia—Calcium Acetate—osteoporosis	0.000547	0.00617	CcSEcCtD
Methazolamide—Photosensitivity reaction—Alendronate—osteoporosis	0.000547	0.00617	CcSEcCtD
Methazolamide—Erythema multiforme—Etidronic acid—osteoporosis	0.000532	0.006	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Alendronate—osteoporosis	0.00053	0.00597	CcSEcCtD
Methazolamide—Decreased appetite—Calcium Acetate—osteoporosis	0.00053	0.00597	CcSEcCtD
Methazolamide—Anorexia—Ergocalciferol—osteoporosis	0.000513	0.00579	CcSEcCtD
Methazolamide—Drowsiness—Calcitriol—osteoporosis	0.000509	0.00574	CcSEcCtD
Methazolamide—Feeling abnormal—Calcium Acetate—osteoporosis	0.000502	0.00566	CcSEcCtD
Methazolamide—Decreased appetite—Ergocalciferol—osteoporosis	0.000468	0.00528	CcSEcCtD
Methazolamide—Urine output increased—Estradiol—osteoporosis	0.000464	0.00523	CcSEcCtD
Methazolamide—Erythema multiforme—Estropipate—osteoporosis	0.000461	0.00519	CcSEcCtD
Methazolamide—Erythema multiforme—Alendronate—osteoporosis	0.000454	0.00511	CcSEcCtD
Methazolamide—Leukopenia—Etidronic acid—osteoporosis	0.000439	0.00495	CcSEcCtD
Methazolamide—Asthenia—Calcium Acetate—osteoporosis	0.000437	0.00493	CcSEcCtD
Methazolamide—Erythema multiforme—Calcitriol—osteoporosis	0.000432	0.00487	CcSEcCtD
Methazolamide—Polyuria—Estradiol—osteoporosis	0.000424	0.00478	CcSEcCtD
Methazolamide—Diarrhoea—Calcium Acetate—osteoporosis	0.000417	0.0047	CcSEcCtD
Methazolamide—Discomfort—Etidronic acid—osteoporosis	0.000412	0.00465	CcSEcCtD
Methazolamide—Dysgeusia—Alendronate—osteoporosis	0.000409	0.00461	CcSEcCtD
Methazolamide—Confusional state—Etidronic acid—osteoporosis	0.000403	0.00455	CcSEcCtD
Methazolamide—Dysgeusia—Ibandronate—osteoporosis	0.000398	0.00449	CcSEcCtD
Methazolamide—Pancytopenia—Zoledronate—osteoporosis	0.000397	0.00447	CcSEcCtD
Methazolamide—Dysgeusia—Calcitriol—osteoporosis	0.00039	0.0044	CcSEcCtD
Methazolamide—Haematuria—Pamidronate—osteoporosis	0.000389	0.00438	CcSEcCtD
Methazolamide—Ill-defined disorder—Alendronate—osteoporosis	0.000388	0.00437	CcSEcCtD
Methazolamide—Vomiting—Calcium Acetate—osteoporosis	0.000387	0.00437	CcSEcCtD
Methazolamide—Asthenia—Ergocalciferol—osteoporosis	0.000386	0.00435	CcSEcCtD
Methazolamide—Vertigo—Estropipate—osteoporosis	0.000381	0.0043	CcSEcCtD
Methazolamide—Agranulocytosis—Pamidronate—osteoporosis	0.00038	0.00429	CcSEcCtD
Methazolamide—Ill-defined disorder—Ibandronate—osteoporosis	0.000377	0.00425	CcSEcCtD
Methazolamide—Malaise—Alendronate—osteoporosis	0.000377	0.00425	CcSEcCtD
Methazolamide—Vertigo—Alendronate—osteoporosis	0.000375	0.00423	CcSEcCtD
Methazolamide—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.000373	0.00421	CcSEcCtD
Methazolamide—Vertigo—Raloxifene—osteoporosis	0.000369	0.00416	CcSEcCtD
Methazolamide—Malaise—Ibandronate—osteoporosis	0.000367	0.00413	CcSEcCtD
Methazolamide—Vertigo—Ibandronate—osteoporosis	0.000365	0.00412	CcSEcCtD
Methazolamide—Nausea—Calcium Acetate—osteoporosis	0.000362	0.00408	CcSEcCtD
Methazolamide—Paraesthesia—Etidronic acid—osteoporosis	0.000359	0.00405	CcSEcCtD
Methazolamide—Tinnitus—Risedronate—osteoporosis	0.000359	0.00405	CcSEcCtD
Methazolamide—Haematuria—Zoledronate—osteoporosis	0.000355	0.004	CcSEcCtD
Methazolamide—Dyspepsia—Etidronic acid—osteoporosis	0.000352	0.00397	CcSEcCtD
Methazolamide—Discomfort—Alendronate—osteoporosis	0.000351	0.00396	CcSEcCtD
Methazolamide—Agranulocytosis—Zoledronate—osteoporosis	0.000347	0.00392	CcSEcCtD
Methazolamide—Anaphylactic shock—Estropipate—osteoporosis	0.000346	0.0039	CcSEcCtD
Methazolamide—Convulsion—Calcitriol—osteoporosis	0.000345	0.00389	CcSEcCtD
Methazolamide—Discomfort—Ibandronate—osteoporosis	0.000342	0.00386	CcSEcCtD
Methazolamide—Discomfort—Calcitriol—osteoporosis	0.000335	0.00378	CcSEcCtD
Methazolamide—Anaphylactic shock—Ibandronate—osteoporosis	0.000332	0.00374	CcSEcCtD
Methazolamide—Feeling abnormal—Etidronic acid—osteoporosis	0.00033	0.00372	CcSEcCtD
Methazolamide—Anaphylactic shock—Calcitriol—osteoporosis	0.000325	0.00366	CcSEcCtD
Methazolamide—Nausea—Ergocalciferol—osteoporosis	0.00032	0.0036	CcSEcCtD
Methazolamide—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.000319	0.0036	CcSEcCtD
Methazolamide—Urticaria—Etidronic acid—osteoporosis	0.000318	0.00358	CcSEcCtD
Methazolamide—Dysgeusia—Pamidronate—osteoporosis	0.000312	0.00352	CcSEcCtD
Methazolamide—Paraesthesia—Estropipate—osteoporosis	0.000311	0.0035	CcSEcCtD
Methazolamide—Malaise—Ethinyl Estradiol—osteoporosis	0.00031	0.00349	CcSEcCtD
Methazolamide—Anorexia—Calcitriol—osteoporosis	0.00031	0.00349	CcSEcCtD
Methazolamide—Somnolence—Estropipate—osteoporosis	0.000308	0.00347	CcSEcCtD
Methazolamide—Dyspepsia—Estropipate—osteoporosis	0.000305	0.00343	CcSEcCtD
Methazolamide—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000304	0.00343	CcSEcCtD
Methazolamide—Vertigo—Risedronate—osteoporosis	0.000301	0.00339	CcSEcCtD
Methazolamide—Dyspepsia—Alendronate—osteoporosis	0.0003	0.00338	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Estropipate—osteoporosis	0.000299	0.00337	CcSEcCtD
Methazolamide—Fatigue—Estropipate—osteoporosis	0.000298	0.00336	CcSEcCtD
Methazolamide—Paraesthesia—Ibandronate—osteoporosis	0.000298	0.00336	CcSEcCtD
Methazolamide—Ill-defined disorder—Pamidronate—osteoporosis	0.000296	0.00333	CcSEcCtD
Methazolamide—Dyspepsia—Raloxifene—osteoporosis	0.000295	0.00333	CcSEcCtD
Methazolamide—Photosensitivity reaction—Estradiol—osteoporosis	0.000294	0.00331	CcSEcCtD
Methazolamide—Dyspepsia—Ibandronate—osteoporosis	0.000292	0.00329	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000289	0.00326	CcSEcCtD
Methazolamide—Discomfort—Ethinyl Estradiol—osteoporosis	0.000289	0.00326	CcSEcCtD
Methazolamide—Somnolence—Calcitriol—osteoporosis	0.000289	0.00326	CcSEcCtD
Methazolamide—Decreased appetite—Ibandronate—osteoporosis	0.000288	0.00325	CcSEcCtD
Methazolamide—Malaise—Pamidronate—osteoporosis	0.000287	0.00324	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000287	0.00323	CcSEcCtD
Methazolamide—Fatigue—Ibandronate—osteoporosis	0.000286	0.00323	CcSEcCtD
Methazolamide—Leukopenia—Pamidronate—osteoporosis	0.000285	0.00322	CcSEcCtD
Methazolamide—Dysgeusia—Zoledronate—osteoporosis	0.000285	0.00321	CcSEcCtD
Methazolamide—Decreased appetite—Calcitriol—osteoporosis	0.000282	0.00318	CcSEcCtD
Methazolamide—Feeling abnormal—Alendronate—osteoporosis	0.000281	0.00317	CcSEcCtD
Methazolamide—Convulsion—Pamidronate—osteoporosis	0.000276	0.00311	CcSEcCtD
Methazolamide—Urticaria—Estropipate—osteoporosis	0.000275	0.0031	CcSEcCtD
Methazolamide—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000274	0.00309	CcSEcCtD
Methazolamide—Diarrhoea—Etidronic acid—osteoporosis	0.000274	0.00309	CcSEcCtD
Methazolamide—Haematuria—Estradiol—osteoporosis	0.000274	0.00308	CcSEcCtD
Methazolamide—Body temperature increased—Estropipate—osteoporosis	0.000274	0.00308	CcSEcCtD
Methazolamide—Feeling abnormal—Ibandronate—osteoporosis	0.000273	0.00308	CcSEcCtD
Methazolamide—Urticaria—Alendronate—osteoporosis	0.000271	0.00305	CcSEcCtD
Methazolamide—Ill-defined disorder—Zoledronate—osteoporosis	0.00027	0.00304	CcSEcCtD
Methazolamide—Body temperature increased—Alendronate—osteoporosis	0.000269	0.00304	CcSEcCtD
Methazolamide—Discomfort—Pamidronate—osteoporosis	0.000268	0.00302	CcSEcCtD
Methazolamide—Body temperature increased—Raloxifene—osteoporosis	0.000265	0.00299	CcSEcCtD
Methazolamide—Urticaria—Ibandronate—osteoporosis	0.000264	0.00297	CcSEcCtD
Methazolamide—Malaise—Zoledronate—osteoporosis	0.000262	0.00296	CcSEcCtD
Methazolamide—Body temperature increased—Ibandronate—osteoporosis	0.000262	0.00296	CcSEcCtD
Methazolamide—Confusional state—Pamidronate—osteoporosis	0.000262	0.00296	CcSEcCtD
Methazolamide—Vertigo—Zoledronate—osteoporosis	0.000261	0.00295	CcSEcCtD
Methazolamide—Leukopenia—Zoledronate—osteoporosis	0.00026	0.00294	CcSEcCtD
Methazolamide—Anaphylactic shock—Pamidronate—osteoporosis	0.00026	0.00293	CcSEcCtD
Methazolamide—Urticaria—Calcitriol—osteoporosis	0.000258	0.00291	CcSEcCtD
Methazolamide—Body temperature increased—Calcitriol—osteoporosis	0.000257	0.0029	CcSEcCtD
Methazolamide—Vomiting—Etidronic acid—osteoporosis	0.000254	0.00287	CcSEcCtD
Methazolamide—Rash—Etidronic acid—osteoporosis	0.000252	0.00284	CcSEcCtD
Methazolamide—Convulsion—Zoledronate—osteoporosis	0.000252	0.00284	CcSEcCtD
Methazolamide—Dermatitis—Etidronic acid—osteoporosis	0.000252	0.00284	CcSEcCtD
Methazolamide—Vertigo—Conjugated Estrogens—osteoporosis	0.000252	0.00284	CcSEcCtD
Methazolamide—Headache—Etidronic acid—osteoporosis	0.000251	0.00283	CcSEcCtD
Methazolamide—Asthenia—Estropipate—osteoporosis	0.000248	0.0028	CcSEcCtD
Methazolamide—Anorexia—Pamidronate—osteoporosis	0.000248	0.00279	CcSEcCtD
Methazolamide—Paraesthesia—Risedronate—osteoporosis	0.000246	0.00277	CcSEcCtD
Methazolamide—Discomfort—Zoledronate—osteoporosis	0.000245	0.00276	CcSEcCtD
Methazolamide—Asthenia—Alendronate—osteoporosis	0.000245	0.00276	CcSEcCtD
Methazolamide—Erythema multiforme—Estradiol—osteoporosis	0.000244	0.00275	CcSEcCtD
Methazolamide—Convulsion—Conjugated Estrogens—osteoporosis	0.000243	0.00274	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000242	0.00273	CcSEcCtD
Methazolamide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000242	0.00273	CcSEcCtD
Methazolamide—Dyspepsia—Risedronate—osteoporosis	0.000241	0.00271	CcSEcCtD
Methazolamide—Tinnitus—Estradiol—osteoporosis	0.00024	0.00271	CcSEcCtD
Methazolamide—Confusional state—Zoledronate—osteoporosis	0.000239	0.0027	CcSEcCtD
Methazolamide—Asthenia—Ibandronate—osteoporosis	0.000238	0.00268	CcSEcCtD
Methazolamide—Nausea—Etidronic acid—osteoporosis	0.000238	0.00268	CcSEcCtD
Methazolamide—Anaphylactic shock—Zoledronate—osteoporosis	0.000237	0.00268	CcSEcCtD
Methazolamide—Diarrhoea—Estropipate—osteoporosis	0.000237	0.00267	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000236	0.00266	CcSEcCtD
Methazolamide—Fatigue—Risedronate—osteoporosis	0.000236	0.00266	CcSEcCtD
Methazolamide—Paraesthesia—Pamidronate—osteoporosis	0.000233	0.00263	CcSEcCtD
Methazolamide—Diarrhoea—Alendronate—osteoporosis	0.000233	0.00263	CcSEcCtD
Methazolamide—Asthenia—Calcitriol—osteoporosis	0.000233	0.00263	CcSEcCtD
Methazolamide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000231	0.00261	CcSEcCtD
Methazolamide—Somnolence—Pamidronate—osteoporosis	0.000231	0.00261	CcSEcCtD
Methazolamide—Diarrhoea—Raloxifene—osteoporosis	0.000229	0.00259	CcSEcCtD
Methazolamide—Dyspepsia—Pamidronate—osteoporosis	0.000229	0.00258	CcSEcCtD
Methazolamide—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000229	0.00258	CcSEcCtD
Methazolamide—Diarrhoea—Ibandronate—osteoporosis	0.000227	0.00256	CcSEcCtD
Methazolamide—Anorexia—Zoledronate—osteoporosis	0.000226	0.00255	CcSEcCtD
Methazolamide—Decreased appetite—Pamidronate—osteoporosis	0.000226	0.00255	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000224	0.00253	CcSEcCtD
Methazolamide—Fatigue—Pamidronate—osteoporosis	0.000224	0.00253	CcSEcCtD
Methazolamide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000223	0.00251	CcSEcCtD
Methazolamide—Diarrhoea—Calcitriol—osteoporosis	0.000222	0.00251	CcSEcCtD
Methazolamide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000222	0.0025	CcSEcCtD
Methazolamide—Vomiting—Estropipate—osteoporosis	0.00022	0.00248	CcSEcCtD
Methazolamide—Dysgeusia—Estradiol—osteoporosis	0.00022	0.00248	CcSEcCtD
Methazolamide—Rash—Estropipate—osteoporosis	0.000218	0.00246	CcSEcCtD
Methazolamide—Dermatitis—Estropipate—osteoporosis	0.000218	0.00246	CcSEcCtD
Methazolamide—Anorexia—Conjugated Estrogens—osteoporosis	0.000218	0.00246	CcSEcCtD
Methazolamide—Urticaria—Risedronate—osteoporosis	0.000217	0.00245	CcSEcCtD
Methazolamide—Headache—Estropipate—osteoporosis	0.000217	0.00244	CcSEcCtD
Methazolamide—Vomiting—Alendronate—osteoporosis	0.000217	0.00244	CcSEcCtD
Methazolamide—Body temperature increased—Risedronate—osteoporosis	0.000216	0.00244	CcSEcCtD
Methazolamide—Rash—Alendronate—osteoporosis	0.000215	0.00242	CcSEcCtD
Methazolamide—Dermatitis—Alendronate—osteoporosis	0.000215	0.00242	CcSEcCtD
Methazolamide—Feeling abnormal—Pamidronate—osteoporosis	0.000214	0.00242	CcSEcCtD
Methazolamide—Headache—Alendronate—osteoporosis	0.000214	0.00241	CcSEcCtD
Methazolamide—Paraesthesia—Zoledronate—osteoporosis	0.000213	0.0024	CcSEcCtD
Methazolamide—Vomiting—Raloxifene—osteoporosis	0.000213	0.0024	CcSEcCtD
Methazolamide—Rash—Raloxifene—osteoporosis	0.000211	0.00238	CcSEcCtD
Methazolamide—Dermatitis—Raloxifene—osteoporosis	0.000211	0.00238	CcSEcCtD
Methazolamide—Somnolence—Zoledronate—osteoporosis	0.000211	0.00238	CcSEcCtD
Methazolamide—Vomiting—Ibandronate—osteoporosis	0.000211	0.00238	CcSEcCtD
Methazolamide—Headache—Raloxifene—osteoporosis	0.00021	0.00237	CcSEcCtD
Methazolamide—Rash—Ibandronate—osteoporosis	0.000209	0.00236	CcSEcCtD
Methazolamide—Dermatitis—Ibandronate—osteoporosis	0.000209	0.00236	CcSEcCtD
Methazolamide—Dyspepsia—Zoledronate—osteoporosis	0.000209	0.00236	CcSEcCtD
Methazolamide—Ill-defined disorder—Estradiol—osteoporosis	0.000208	0.00235	CcSEcCtD
Methazolamide—Headache—Ibandronate—osteoporosis	0.000208	0.00234	CcSEcCtD
Methazolamide—Vomiting—Calcitriol—osteoporosis	0.000207	0.00233	CcSEcCtD
Methazolamide—Decreased appetite—Zoledronate—osteoporosis	0.000206	0.00233	CcSEcCtD
Methazolamide—Nausea—Estropipate—osteoporosis	0.000206	0.00232	CcSEcCtD
Methazolamide—Body temperature increased—Pamidronate—osteoporosis	0.000206	0.00232	CcSEcCtD
Methazolamide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000205	0.00232	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000205	0.00231	CcSEcCtD
Methazolamide—Rash—Calcitriol—osteoporosis	0.000205	0.00231	CcSEcCtD
Methazolamide—Fatigue—Zoledronate—osteoporosis	0.000205	0.00231	CcSEcCtD
Methazolamide—Dermatitis—Calcitriol—osteoporosis	0.000205	0.00231	CcSEcCtD
Methazolamide—Headache—Calcitriol—osteoporosis	0.000204	0.00229	CcSEcCtD
Methazolamide—Somnolence—Conjugated Estrogens—osteoporosis	0.000203	0.00229	CcSEcCtD
Methazolamide—Nausea—Alendronate—osteoporosis	0.000202	0.00228	CcSEcCtD
Methazolamide—Malaise—Estradiol—osteoporosis	0.000202	0.00228	CcSEcCtD
Methazolamide—Vertigo—Estradiol—osteoporosis	0.000201	0.00227	CcSEcCtD
Methazolamide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000201	0.00227	CcSEcCtD
Methazolamide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000201	0.00227	CcSEcCtD
Methazolamide—Nausea—Raloxifene—osteoporosis	0.000199	0.00225	CcSEcCtD
Methazolamide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000199	0.00224	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000197	0.00223	CcSEcCtD
Methazolamide—Fatigue—Conjugated Estrogens—osteoporosis	0.000197	0.00222	CcSEcCtD
Methazolamide—Nausea—Ibandronate—osteoporosis	0.000197	0.00222	CcSEcCtD
Methazolamide—Asthenia—Risedronate—osteoporosis	0.000196	0.00221	CcSEcCtD
Methazolamide—Feeling abnormal—Zoledronate—osteoporosis	0.000196	0.00221	CcSEcCtD
Methazolamide—Nausea—Calcitriol—osteoporosis	0.000193	0.00218	CcSEcCtD
Methazolamide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000192	0.00216	CcSEcCtD
Methazolamide—Urticaria—Zoledronate—osteoporosis	0.000189	0.00213	CcSEcCtD
Methazolamide—Discomfort—Estradiol—osteoporosis	0.000189	0.00213	CcSEcCtD
Methazolamide—Body temperature increased—Zoledronate—osteoporosis	0.000188	0.00212	CcSEcCtD
Methazolamide—Diarrhoea—Risedronate—osteoporosis	0.000187	0.00211	CcSEcCtD
Methazolamide—Asthenia—Pamidronate—osteoporosis	0.000187	0.0021	CcSEcCtD
Methazolamide—Confusional state—Estradiol—osteoporosis	0.000185	0.00208	CcSEcCtD
Methazolamide—Anaphylactic shock—Estradiol—osteoporosis	0.000183	0.00206	CcSEcCtD
Methazolamide—Urticaria—Conjugated Estrogens—osteoporosis	0.000182	0.00205	CcSEcCtD
Methazolamide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000181	0.00204	CcSEcCtD
Methazolamide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000178	0.00201	CcSEcCtD
Methazolamide—Diarrhoea—Pamidronate—osteoporosis	0.000178	0.00201	CcSEcCtD
Methazolamide—Rash—Ethinyl Estradiol—osteoporosis	0.000177	0.00199	CcSEcCtD
Methazolamide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000177	0.00199	CcSEcCtD
Methazolamide—Headache—Ethinyl Estradiol—osteoporosis	0.000176	0.00198	CcSEcCtD
Methazolamide—Vomiting—Risedronate—osteoporosis	0.000174	0.00196	CcSEcCtD
Methazolamide—Rash—Risedronate—osteoporosis	0.000172	0.00194	CcSEcCtD
Methazolamide—Dermatitis—Risedronate—osteoporosis	0.000172	0.00194	CcSEcCtD
Methazolamide—Headache—Risedronate—osteoporosis	0.000171	0.00193	CcSEcCtD
Methazolamide—Asthenia—Zoledronate—osteoporosis	0.00017	0.00192	CcSEcCtD
Methazolamide—Nausea—Ethinyl Estradiol—osteoporosis	0.000167	0.00188	CcSEcCtD
Methazolamide—Vomiting—Pamidronate—osteoporosis	0.000165	0.00186	CcSEcCtD
Methazolamide—Paraesthesia—Estradiol—osteoporosis	0.000164	0.00185	CcSEcCtD
Methazolamide—Asthenia—Conjugated Estrogens—osteoporosis	0.000164	0.00185	CcSEcCtD
Methazolamide—Rash—Pamidronate—osteoporosis	0.000164	0.00185	CcSEcCtD
Methazolamide—Dermatitis—Pamidronate—osteoporosis	0.000164	0.00185	CcSEcCtD
Methazolamide—Headache—Pamidronate—osteoporosis	0.000163	0.00184	CcSEcCtD
Methazolamide—Somnolence—Estradiol—osteoporosis	0.000163	0.00183	CcSEcCtD
Methazolamide—Diarrhoea—Zoledronate—osteoporosis	0.000162	0.00183	CcSEcCtD
Methazolamide—Nausea—Risedronate—osteoporosis	0.000162	0.00183	CcSEcCtD
Methazolamide—Dyspepsia—Estradiol—osteoporosis	0.000161	0.00182	CcSEcCtD
Methazolamide—Decreased appetite—Estradiol—osteoporosis	0.000159	0.00179	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Estradiol—osteoporosis	0.000158	0.00178	CcSEcCtD
Methazolamide—Fatigue—Estradiol—osteoporosis	0.000158	0.00178	CcSEcCtD
Methazolamide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000156	0.00176	CcSEcCtD
Methazolamide—Nausea—Pamidronate—osteoporosis	0.000154	0.00174	CcSEcCtD
Methazolamide—Vomiting—Zoledronate—osteoporosis	0.000151	0.0017	CcSEcCtD
Methazolamide—Feeling abnormal—Estradiol—osteoporosis	0.000151	0.0017	CcSEcCtD
Methazolamide—Rash—Zoledronate—osteoporosis	0.00015	0.00169	CcSEcCtD
Methazolamide—Dermatitis—Zoledronate—osteoporosis	0.00015	0.00169	CcSEcCtD
Methazolamide—Headache—Zoledronate—osteoporosis	0.000149	0.00168	CcSEcCtD
Methazolamide—Vomiting—Conjugated Estrogens—osteoporosis	0.000145	0.00164	CcSEcCtD
Methazolamide—Urticaria—Estradiol—osteoporosis	0.000145	0.00164	CcSEcCtD
Methazolamide—Body temperature increased—Estradiol—osteoporosis	0.000145	0.00163	CcSEcCtD
Methazolamide—Rash—Conjugated Estrogens—osteoporosis	0.000144	0.00163	CcSEcCtD
Methazolamide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000144	0.00162	CcSEcCtD
Methazolamide—Headache—Conjugated Estrogens—osteoporosis	0.000143	0.00162	CcSEcCtD
Methazolamide—Nausea—Zoledronate—osteoporosis	0.000141	0.00159	CcSEcCtD
Methazolamide—Nausea—Conjugated Estrogens—osteoporosis	0.000136	0.00153	CcSEcCtD
Methazolamide—Asthenia—Estradiol—osteoporosis	0.000131	0.00148	CcSEcCtD
Methazolamide—Diarrhoea—Estradiol—osteoporosis	0.000125	0.00141	CcSEcCtD
Methazolamide—Vomiting—Estradiol—osteoporosis	0.000116	0.00131	CcSEcCtD
Methazolamide—Rash—Estradiol—osteoporosis	0.000115	0.0013	CcSEcCtD
Methazolamide—Dermatitis—Estradiol—osteoporosis	0.000115	0.0013	CcSEcCtD
Methazolamide—Headache—Estradiol—osteoporosis	0.000115	0.00129	CcSEcCtD
Methazolamide—Nausea—Estradiol—osteoporosis	0.000109	0.00123	CcSEcCtD
Methazolamide—CYP2E1—Metapathway biotransformation—CYP19A1—osteoporosis	4.38e-05	0.000651	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.37e-05	0.000648	CbGpPWpGaD
Methazolamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.37e-05	0.000648	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PSMA5—osteoporosis	4.33e-05	0.000643	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PSMA2—osteoporosis	4.33e-05	0.000643	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PSMA2—osteoporosis	4.33e-05	0.000643	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PSMA5—osteoporosis	4.33e-05	0.000643	CbGpPWpGaD
Methazolamide—CA2—Metabolism—TPI1—osteoporosis	4.28e-05	0.000636	CbGpPWpGaD
Methazolamide—CA9—Metabolism—IDH2—osteoporosis	4.24e-05	0.00063	CbGpPWpGaD
Methazolamide—CA4—Metabolism—P4HB—osteoporosis	4.2e-05	0.000623	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	4.14e-05	0.000615	CbGpPWpGaD
Methazolamide—CA4—Metabolism—GAPDH—osteoporosis	4.12e-05	0.000612	CbGpPWpGaD
Methazolamide—CA1—Metabolism—TPI1—osteoporosis	4.1e-05	0.000609	CbGpPWpGaD
Methazolamide—CA12—Metabolism—ENO1—osteoporosis	4.07e-05	0.000604	CbGpPWpGaD
Methazolamide—CA2—Metabolism—P4HB—osteoporosis	4.02e-05	0.000598	CbGpPWpGaD
Methazolamide—CA4—Metabolism—RAP1A—osteoporosis	4.01e-05	0.000596	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PSMA5—osteoporosis	4.01e-05	0.000595	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PSMA2—osteoporosis	4.01e-05	0.000595	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CYP27A1—osteoporosis	3.99e-05	0.000592	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.98e-05	0.000591	CbGpPWpGaD
Methazolamide—CA2—Metabolism—GAPDH—osteoporosis	3.95e-05	0.000587	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	3.93e-05	0.000583	CbGpPWpGaD
Methazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.88e-05	0.000577	CbGpPWpGaD
Methazolamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.88e-05	0.000576	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ACP5—osteoporosis	3.88e-05	0.000576	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	3.87e-05	0.000575	CbGpPWpGaD
Methazolamide—CA1—Metabolism—P4HB—osteoporosis	3.86e-05	0.000573	CbGpPWpGaD
Methazolamide—CA14—Metabolism—CYP19A1—osteoporosis	3.86e-05	0.000573	CbGpPWpGaD
Methazolamide—CA2—Metabolism—RAP1A—osteoporosis	3.85e-05	0.000571	CbGpPWpGaD
Methazolamide—CA1—Metabolism—GAPDH—osteoporosis	3.79e-05	0.000562	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.77e-05	0.00056	CbGpPWpGaD
Methazolamide—CA6—Metabolism—CYP19A1—osteoporosis	3.76e-05	0.000558	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—CYP19A1—osteoporosis	3.76e-05	0.000558	CbGpPWpGaD
Methazolamide—CA1—Metabolism—RAP1A—osteoporosis	3.69e-05	0.000548	CbGpPWpGaD
Methazolamide—CA9—Metabolism—TPI1—osteoporosis	3.61e-05	0.000536	CbGpPWpGaD
Methazolamide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.57e-05	0.00053	CbGpPWpGaD
Methazolamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.54e-05	0.000526	CbGpPWpGaD
Methazolamide—CA7—Metabolism—CYP19A1—osteoporosis	3.51e-05	0.000521	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—CYP19A1—osteoporosis	3.51e-05	0.000521	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	3.43e-05	0.000509	CbGpPWpGaD
Methazolamide—CA9—Metabolism—P4HB—osteoporosis	3.39e-05	0.000504	CbGpPWpGaD
Methazolamide—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	3.38e-05	0.000502	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GAPDH—osteoporosis	3.33e-05	0.000494	CbGpPWpGaD
Methazolamide—CA12—Metabolism—CYP19A1—osteoporosis	3.25e-05	0.000483	CbGpPWpGaD
Methazolamide—CA4—Metabolism—ENO1—osteoporosis	3.24e-05	0.000482	CbGpPWpGaD
Methazolamide—CA9—Metabolism—RAP1A—osteoporosis	3.24e-05	0.000482	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.22e-05	0.000478	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PSMA5—osteoporosis	3.2e-05	0.000475	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PSMA2—osteoporosis	3.2e-05	0.000475	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	3.15e-05	0.000469	CbGpPWpGaD
Methazolamide—CA14—Metabolism—ADCY5—osteoporosis	3.15e-05	0.000468	CbGpPWpGaD
Methazolamide—CA14—Metabolism—GPX1—osteoporosis	3.14e-05	0.000467	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.14e-05	0.000466	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	3.13e-05	0.000464	CbGpPWpGaD
Methazolamide—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	3.11e-05	0.000462	CbGpPWpGaD
Methazolamide—CA2—Metabolism—ENO1—osteoporosis	3.11e-05	0.000462	CbGpPWpGaD
Methazolamide—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	3.08e-05	0.000458	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—ADCY5—osteoporosis	3.07e-05	0.000456	CbGpPWpGaD
Methazolamide—CA6—Metabolism—ADCY5—osteoporosis	3.07e-05	0.000456	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PSMA2—osteoporosis	3.06e-05	0.000455	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PSMA5—osteoporosis	3.06e-05	0.000455	CbGpPWpGaD
Methazolamide—CA6—Metabolism—GPX1—osteoporosis	3.06e-05	0.000455	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—GPX1—osteoporosis	3.06e-05	0.000455	CbGpPWpGaD
Methazolamide—CA1—Metabolism—ENO1—osteoporosis	2.98e-05	0.000443	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PSMA5—osteoporosis	2.94e-05	0.000436	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PSMA2—osteoporosis	2.94e-05	0.000436	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.93e-05	0.000436	CbGpPWpGaD
Methazolamide—CA14—Metabolism—MTHFR—osteoporosis	2.9e-05	0.000431	CbGpPWpGaD
Methazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.88e-05	0.000428	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—ADCY5—osteoporosis	2.87e-05	0.000426	CbGpPWpGaD
Methazolamide—CA7—Metabolism—ADCY5—osteoporosis	2.87e-05	0.000426	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.86e-05	0.000425	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—GPX1—osteoporosis	2.86e-05	0.000424	CbGpPWpGaD
Methazolamide—CA7—Metabolism—GPX1—osteoporosis	2.86e-05	0.000424	CbGpPWpGaD
Methazolamide—CA6—Metabolism—MTHFR—osteoporosis	2.83e-05	0.00042	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—MTHFR—osteoporosis	2.83e-05	0.00042	CbGpPWpGaD
Methazolamide—CYP2E1—Biological oxidations—POMC—osteoporosis	2.67e-05	0.000397	CbGpPWpGaD
Methazolamide—CA12—Metabolism—ADCY5—osteoporosis	2.66e-05	0.000395	CbGpPWpGaD
Methazolamide—CA12—Metabolism—GPX1—osteoporosis	2.65e-05	0.000393	CbGpPWpGaD
Methazolamide—CA7—Metabolism—MTHFR—osteoporosis	2.64e-05	0.000392	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—MTHFR—osteoporosis	2.64e-05	0.000392	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ENO1—osteoporosis	2.62e-05	0.000389	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CYP19A1—osteoporosis	2.59e-05	0.000385	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PSMA2—osteoporosis	2.58e-05	0.000384	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PSMA5—osteoporosis	2.58e-05	0.000384	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PKM—osteoporosis	2.52e-05	0.000374	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—FDPS—osteoporosis	2.52e-05	0.000374	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.51e-05	0.000372	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CYP19A1—osteoporosis	2.49e-05	0.000369	CbGpPWpGaD
Methazolamide—CA12—Metabolism—MTHFR—osteoporosis	2.44e-05	0.000363	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PGLS—osteoporosis	2.39e-05	0.000355	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GPD2—osteoporosis	2.39e-05	0.000355	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CYP19A1—osteoporosis	2.38e-05	0.000354	CbGpPWpGaD
Methazolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.33e-05	0.000347	CbGpPWpGaD
Methazolamide—CA14—Metabolism—POMC—osteoporosis	2.32e-05	0.000344	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.29e-05	0.00034	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—IL6—osteoporosis	2.27e-05	0.000337	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—POMC—osteoporosis	2.26e-05	0.000336	CbGpPWpGaD
Methazolamide—CA6—Metabolism—POMC—osteoporosis	2.26e-05	0.000336	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.19e-05	0.000326	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ATIC—osteoporosis	2.19e-05	0.000324	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PNP—osteoporosis	2.19e-05	0.000324	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.13e-05	0.000317	CbGpPWpGaD
Methazolamide—CA4—Metabolism—ADCY5—osteoporosis	2.12e-05	0.000315	CbGpPWpGaD
Methazolamide—CA4—Metabolism—GPX1—osteoporosis	2.11e-05	0.000314	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—POMC—osteoporosis	2.11e-05	0.000313	CbGpPWpGaD
Methazolamide—CA7—Metabolism—POMC—osteoporosis	2.11e-05	0.000313	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CYP19A1—osteoporosis	2.1e-05	0.000311	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.06e-05	0.000306	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—POMC—osteoporosis	2.06e-05	0.000306	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.03e-05	0.000302	CbGpPWpGaD
Methazolamide—CA2—Metabolism—ADCY5—osteoporosis	2.03e-05	0.000302	CbGpPWpGaD
Methazolamide—CA2—Metabolism—GPX1—osteoporosis	2.02e-05	0.000301	CbGpPWpGaD
Methazolamide—CA12—Metabolism—POMC—osteoporosis	1.95e-05	0.00029	CbGpPWpGaD
Methazolamide—CA4—Metabolism—MTHFR—osteoporosis	1.95e-05	0.000289	CbGpPWpGaD
Methazolamide—CA1—Metabolism—ADCY5—osteoporosis	1.95e-05	0.000289	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PKM—osteoporosis	1.94e-05	0.000289	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—FDPS—osteoporosis	1.94e-05	0.000289	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.94e-05	0.000289	CbGpPWpGaD
Methazolamide—CA1—Metabolism—GPX1—osteoporosis	1.94e-05	0.000288	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—POMC—osteoporosis	1.9e-05	0.000282	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—POMC—osteoporosis	1.88e-05	0.000279	CbGpPWpGaD
Methazolamide—CA2—Metabolism—MTHFR—osteoporosis	1.87e-05	0.000277	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CA2—osteoporosis	1.86e-05	0.000276	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—OXCT1—osteoporosis	1.86e-05	0.000276	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PGLS—osteoporosis	1.84e-05	0.000274	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GPD2—osteoporosis	1.84e-05	0.000274	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MGLL—osteoporosis	1.81e-05	0.000269	CbGpPWpGaD
Methazolamide—CA1—Metabolism—MTHFR—osteoporosis	1.79e-05	0.000266	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PKM—osteoporosis	1.79e-05	0.000266	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—FDPS—osteoporosis	1.79e-05	0.000266	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PKM—osteoporosis	1.77e-05	0.000263	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—FDPS—osteoporosis	1.77e-05	0.000263	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ADCY5—osteoporosis	1.71e-05	0.000254	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GPX1—osteoporosis	1.71e-05	0.000253	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PGLS—osteoporosis	1.7e-05	0.000252	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GPD2—osteoporosis	1.7e-05	0.000252	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ATIC—osteoporosis	1.69e-05	0.00025	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PNP—osteoporosis	1.69e-05	0.00025	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GPD2—osteoporosis	1.68e-05	0.00025	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PGLS—osteoporosis	1.68e-05	0.00025	CbGpPWpGaD
Methazolamide—CA9—Metabolism—MTHFR—osteoporosis	1.57e-05	0.000234	CbGpPWpGaD
Methazolamide—CA4—Metabolism—POMC—osteoporosis	1.56e-05	0.000231	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PNP—osteoporosis	1.55e-05	0.00023	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ATIC—osteoporosis	1.55e-05	0.00023	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—IDH2—osteoporosis	1.54e-05	0.000229	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PNP—osteoporosis	1.54e-05	0.000228	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ATIC—osteoporosis	1.54e-05	0.000228	CbGpPWpGaD
Methazolamide—CA2—Metabolism—POMC—osteoporosis	1.49e-05	0.000222	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP27A1—osteoporosis	1.45e-05	0.000215	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CA2—osteoporosis	1.43e-05	0.000213	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—OXCT1—osteoporosis	1.43e-05	0.000213	CbGpPWpGaD
Methazolamide—CA1—Metabolism—POMC—osteoporosis	1.43e-05	0.000213	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ACP5—osteoporosis	1.41e-05	0.000209	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MGLL—osteoporosis	1.4e-05	0.000207	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CA2—osteoporosis	1.32e-05	0.000196	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—OXCT1—osteoporosis	1.32e-05	0.000196	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.32e-05	0.000196	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—TPI1—osteoporosis	1.31e-05	0.000194	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CA2—osteoporosis	1.31e-05	0.000194	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—OXCT1—osteoporosis	1.31e-05	0.000194	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MGLL—osteoporosis	1.28e-05	0.000191	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MGLL—osteoporosis	1.27e-05	0.000189	CbGpPWpGaD
Methazolamide—CA9—Metabolism—POMC—osteoporosis	1.26e-05	0.000187	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—POMC—osteoporosis	1.24e-05	0.000184	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—P4HB—osteoporosis	1.23e-05	0.000183	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GAPDH—osteoporosis	1.21e-05	0.000179	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.2e-05	0.000178	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—IDH2—osteoporosis	1.19e-05	0.000176	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—RAP1A—osteoporosis	1.18e-05	0.000175	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PKM—osteoporosis	1.17e-05	0.000174	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—FDPS—osteoporosis	1.17e-05	0.000174	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.12e-05	0.000166	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PGLS—osteoporosis	1.11e-05	0.000165	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GPD2—osteoporosis	1.11e-05	0.000165	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—IDH2—osteoporosis	1.09e-05	0.000162	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ACP5—osteoporosis	1.09e-05	0.000161	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—IDH2—osteoporosis	1.08e-05	0.000161	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.07e-05	0.000159	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.03e-05	0.000153	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.02e-05	0.000151	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PNP—osteoporosis	1.01e-05	0.000151	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ATIC—osteoporosis	1.01e-05	0.000151	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TPI1—osteoporosis	1.01e-05	0.00015	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ACP5—osteoporosis	9.99e-06	0.000148	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ACP5—osteoporosis	9.91e-06	0.000147	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.78e-06	0.000145	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ENO1—osteoporosis	9.51e-06	0.000141	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—P4HB—osteoporosis	9.5e-06	0.000141	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PSMA2—osteoporosis	9.37e-06	0.000139	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PSMA5—osteoporosis	9.37e-06	0.000139	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GAPDH—osteoporosis	9.32e-06	0.000138	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TPI1—osteoporosis	9.29e-06	0.000138	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TPI1—osteoporosis	9.21e-06	0.000137	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—RAP1A—osteoporosis	9.08e-06	0.000135	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—P4HB—osteoporosis	8.73e-06	0.00013	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—P4HB—osteoporosis	8.66e-06	0.000129	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—OXCT1—osteoporosis	8.62e-06	0.000128	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CA2—osteoporosis	8.62e-06	0.000128	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GAPDH—osteoporosis	8.57e-06	0.000127	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GAPDH—osteoporosis	8.5e-06	0.000126	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MGLL—osteoporosis	8.4e-06	0.000125	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—RAP1A—osteoporosis	8.35e-06	0.000124	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—RAP1A—osteoporosis	8.28e-06	0.000123	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.92e-06	0.000118	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP19A1—osteoporosis	7.6e-06	0.000113	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ENO1—osteoporosis	7.34e-06	0.000109	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PSMA5—osteoporosis	7.23e-06	0.000107	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PSMA2—osteoporosis	7.23e-06	0.000107	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.22e-06	0.000107	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—IDH2—osteoporosis	7.14e-06	0.000106	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ENO1—osteoporosis	6.75e-06	0.0001	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP27A1—osteoporosis	6.72e-06	9.97e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ENO1—osteoporosis	6.69e-06	9.94e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PSMA2—osteoporosis	6.65e-06	9.88e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PSMA5—osteoporosis	6.65e-06	9.88e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PSMA5—osteoporosis	6.59e-06	9.79e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PSMA2—osteoporosis	6.59e-06	9.79e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ACP5—osteoporosis	6.53e-06	9.7e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ADCY5—osteoporosis	6.21e-06	9.23e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GPX1—osteoporosis	6.19e-06	9.19e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TPI1—osteoporosis	6.07e-06	9.02e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP19A1—osteoporosis	5.87e-06	8.71e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MTHFR—osteoporosis	5.71e-06	8.49e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—P4HB—osteoporosis	5.71e-06	8.48e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GAPDH—osteoporosis	5.6e-06	8.32e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—RAP1A—osteoporosis	5.46e-06	8.11e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP19A1—osteoporosis	5.4e-06	8.01e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP19A1—osteoporosis	5.35e-06	7.94e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ADCY5—osteoporosis	4.79e-06	7.12e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GPX1—osteoporosis	4.78e-06	7.09e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—POMC—osteoporosis	4.57e-06	6.79e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ENO1—osteoporosis	4.41e-06	6.55e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ADCY5—osteoporosis	4.41e-06	6.55e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MTHFR—osteoporosis	4.41e-06	6.55e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GPX1—osteoporosis	4.39e-06	6.52e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ADCY5—osteoporosis	4.37e-06	6.49e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GPX1—osteoporosis	4.36e-06	6.47e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PSMA2—osteoporosis	4.35e-06	6.46e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PSMA5—osteoporosis	4.35e-06	6.46e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MTHFR—osteoporosis	4.05e-06	6.02e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MTHFR—osteoporosis	4.02e-06	5.97e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.53e-06	5.24e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—POMC—osteoporosis	3.53e-06	5.24e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—POMC—osteoporosis	3.24e-06	4.82e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—POMC—osteoporosis	3.21e-06	4.77e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ADCY5—osteoporosis	2.88e-06	4.28e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GPX1—osteoporosis	2.87e-06	4.27e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTHFR—osteoporosis	2.65e-06	3.94e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—POMC—osteoporosis	2.12e-06	3.15e-05	CbGpPWpGaD
